Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Confirmatory Trial of Adjunctive N-acetylcysteine to Prevent Post Tuberculosis Lung Disease (NAC-PTLD) - A TB SEQUEL II Substudy

NCT06909799 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT06909799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Confirmatory Trial of Adjunctive N-acetylcysteine to Prevent Post Tuberculosis Lung Disease (NAC-PTLD) - A TB SEQUEL II Substudy
Lead sponsor
The Aurum Institute NPC
Phase
Not applicable
Overall status
Recruiting
Start date
April 28, 2025
Completion date
December 31, 2027
Enrollment
242 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis (tb)